Phase I trial of oral talactoferrin alfa in refractory solid tumors

By Hayes Teresa   Falchook Gerald   Varadhachary Gauri   Smith Dori   Davis Lisa   Dhingra Hari   Hayes Benjamin   Varadhachary Atul  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 233-240

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 trial of Anvirzel™ in patients with refractory solid tumors

By Mekhail Tarek   Kaur Hanspreet   Ganapathi Ram   Budd G.   Elson Paul   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 423-427

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

By Ho Cheryl   Davies Angela   Sangha Randeep   Lau Derick   Lara Primo   Chew Helen   Beckett Laurel   Mack Philip   Riess Jonathan   Gandara David  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1587-1591

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

By Hubbard Joleen   Erlichman Charles   Toft David   Qin Rui   Stensgard Bridget   Felten Sara   Ten Eyck Cynthia   Batzel Gretchen   Ivy S.   Haluska Paul  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 473-480

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Clinical and Pharmacokinetic Study of Fenretinide Combined with Paclitaxel and Cisplatin for Refractory Solid Tumors

By Otterson G.   Lavelle J.   Villalona-Calero M.   Shah M.   Wei X.   Chan K.   Fischer B.   Grever M.  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 555-562

Springer Publishing Company

Access to resources Recommend Favorite